Gilead Sciences
GILD
#95
Rank
NZ$305.96 B
Marketcap
NZ$246.46
Share price
-0.56%
Change (1 day)
28.78%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): NZ$17.01 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are NZ$29.08 Billion. In 2024 the company made an earning of NZ$1.17 Billion a decrease over its 2023 earnings that were of NZ$11.70 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$17.01 B1345.14%
2024 NZ$1.17 B-89.94%
2023 NZ$11.70 B17.97%
2022 NZ$9.92 B-29.77%
2021 NZ$14.12 B395.99%
2020 NZ$2.84 B-67.66%
2019 NZ$8.80 B-33.84%
2018 NZ$13.31 B-42.35%
2017 NZ$23.09 B-20.87%
2016 NZ$29.18 B-21.06%
2015 NZ$36.96 B45.8%
2014 NZ$25.35 B253.01%
2013 NZ$7.18 B16.51%
2012 NZ$6.16 B-1.07%
2011 NZ$6.23 B-6.71%
2010 NZ$6.67 B11.75%
2009 NZ$5.97 B29.5%
2008 NZ$4.61 B19.11%
2007 NZ$3.87 B-455.74%
2006 -NZ$1.09 Billion-154.93%
2005 NZ$1.98 B76.99%
2004 NZ$1.12 B-266.16%
2003 -NZ$0.68 Billion-638.24%
2002 NZ$0.12 B31.5%
2001 NZ$95.26 M-242.15%
2000 -NZ$67.03 Million-40.2%
1999 -NZ$0.12 Billion31.85%
1998 -NZ$85 Million8.73%
1997 -NZ$78.18 Million27.22%
1996 -NZ$61.45 Million
1994 -NZ$58.55 Million26.57%
1993 -NZ$46.26 Million46.49%
1992 -NZ$31.58 Million362.5%
1991 -NZ$6.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$55.29 B 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.22 B 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.83 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.40 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$14.07 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$3.24 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$1.69 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$7.61 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.41 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA